Financial Summary (All financials)
In millions, except per share items | Dec-31-08 | Sep-09-08 | Dec-31-07 | Dec-31-05 | Sep-09-05 | Dec-31-04 | Sep-09-04 | Dec-31-03 |
Revenues | 0.3 | 11.3 | 0.3 | 0.2 | 10.3 | 0.1 | 10.2 | 1.4 |
Revenue growth | 7.5% | | | 37.7% | 1.8% | -91.0% | 1.3% | 1964.3% |
Cost of goods sold | 0.0 | 0.1 | 0.0 | 0.1 | 0.0 | 0.3 | 0.0 | 0.2 |
Gross profit | 0.3 | 11.2 | 0.3 | 0.0 | 10.3 | -0.2 | 10.2 | 1.3 |
Gross margin | 85.8% | 99.0% | 92.9% | 20.7% | 100.0% | -123.1% | 100.0% | 87.6% |
Selling, general and administrative | 0.6 | 22.1 | 0.7 | | | | | |
Research and development | 0.0 | 20.0 | 0.0 | 0.0 | 20.0 | 0.0 | 20.0 | 0.1 |
General and administrative | | | | 0.9 | 19.7 | 0.6 | 18.8 | 0.6 |
EBIT | -0.6 | -124.1 | -0.6 | -1.0 | -122.0 | -0.9 | -121.0 | 0.5 |
EBIT margin | -174.1% | -1093.4% | -198.6% | -555.9% | -1180.4% | -691.5% | -1191.5% | 34.7% |
Pre-tax income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Net income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Net margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
|
Diluted EPS | $0.00 | | $0.00 | $0.00 | | $0.00 | | $0.00 |
Shares outstanding (diluted) | 17.0 | | 17.0 | 16.9 | | 16.9 | | 17.4 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|